PL3315128T3 - Schemat dawkowania rowatireliny w ataksji związanej z zwyrodnieniem rdzeniowo-móżdżkowym - Google Patents
Schemat dawkowania rowatireliny w ataksji związanej z zwyrodnieniem rdzeniowo-móżdżkowymInfo
- Publication number
- PL3315128T3 PL3315128T3 PL15896367T PL15896367T PL3315128T3 PL 3315128 T3 PL3315128 T3 PL 3315128T3 PL 15896367 T PL15896367 T PL 15896367T PL 15896367 T PL15896367 T PL 15896367T PL 3315128 T3 PL3315128 T3 PL 3315128T3
- Authority
- PL
- Poland
- Prior art keywords
- rovatirelin
- dosing regimen
- spinocerebellar degeneration
- ataxia associated
- ataxia
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2015/068438 WO2016208045A1 (ja) | 2015-06-26 | 2015-06-26 | 脊髄小脳変性症における運動失調の治療剤の投与レジメン |
| EP15896367.8A EP3315128B1 (en) | 2015-06-26 | 2015-06-26 | Dosing regimen of rovatirelin for ataxia associated with spinocerebellar degeneration |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3315128T3 true PL3315128T3 (pl) | 2021-10-04 |
Family
ID=57585246
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL15896367T PL3315128T3 (pl) | 2015-06-26 | 2015-06-26 | Schemat dawkowania rowatireliny w ataksji związanej z zwyrodnieniem rdzeniowo-móżdżkowym |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20180147189A1 (pl) |
| EP (1) | EP3315128B1 (pl) |
| CN (1) | CN107735089A (pl) |
| DK (1) | DK3315128T3 (pl) |
| ES (1) | ES2880388T3 (pl) |
| PL (1) | PL3315128T3 (pl) |
| WO (1) | WO2016208045A1 (pl) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6319902B1 (en) * | 1997-08-22 | 2001-11-20 | Shionogi & Co., Ltd. | Peptide derivatives having thiazolyl-alanine residue |
| JP5196641B2 (ja) * | 2004-09-09 | 2013-05-15 | 塩野義製薬株式会社 | 脊髄小脳変性症治療剤 |
| TWI350754B (en) * | 2004-09-09 | 2011-10-21 | Shionogi & Co | A pharmaceutical composition for treating spinocerebellar ataxia |
-
2015
- 2015-06-26 CN CN201580081092.3A patent/CN107735089A/zh active Pending
- 2015-06-26 WO PCT/JP2015/068438 patent/WO2016208045A1/ja active Application Filing
- 2015-06-26 EP EP15896367.8A patent/EP3315128B1/en active Active
- 2015-06-26 ES ES15896367T patent/ES2880388T3/es active Active
- 2015-06-26 US US15/736,400 patent/US20180147189A1/en not_active Abandoned
- 2015-06-26 DK DK15896367.8T patent/DK3315128T3/da active
- 2015-06-26 PL PL15896367T patent/PL3315128T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20180147189A1 (en) | 2018-05-31 |
| EP3315128A4 (en) | 2019-02-20 |
| ES2880388T3 (es) | 2021-11-24 |
| CN107735089A (zh) | 2018-02-23 |
| EP3315128A1 (en) | 2018-05-02 |
| WO2016208045A1 (ja) | 2016-12-29 |
| EP3315128B1 (en) | 2021-05-19 |
| DK3315128T3 (da) | 2021-07-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1253507A1 (zh) | 抗 ror1 抗體 | |
| HK1254836A1 (zh) | 抗-ror1抗體 | |
| HK1256116A1 (zh) | 抗lag-3抗體 | |
| GB201521393D0 (en) | Antibodies | |
| GB201521391D0 (en) | Antibodies | |
| HK1246804A1 (zh) | Tau結合抗體 | |
| GB201521382D0 (en) | Antibodies | |
| IL253633A0 (en) | Anti-transthyretin antibodies | |
| IL255323A0 (en) | Anti-fcrn antibodies | |
| HK1255056A1 (zh) | 抗cd115抗體 | |
| HUE055109T2 (hu) | Adagolási rendek TF elleni antitest és gyógyszer konjugátumaihoz | |
| HUE059592T2 (hu) | Anti-transztiretin antitestek | |
| GB201510451D0 (en) | Actuated-valve metering | |
| GB201509907D0 (en) | Antibodies | |
| IL248145A0 (en) | ang2 antibodies | |
| KR101819190B9 (ko) | 미세조류 파괴용 조성물 | |
| GB201516836D0 (en) | Dosing regimen of combination | |
| GB201522394D0 (en) | Antibodies | |
| PL3315128T3 (pl) | Schemat dawkowania rowatireliny w ataksji związanej z zwyrodnieniem rdzeniowo-móżdżkowym | |
| GB201503438D0 (en) | Antibodies | |
| IL284022B1 (en) | Anti-transthyretin antibodies | |
| GB201518728D0 (en) | Antibodies | |
| GB201507310D0 (en) | Hopper stopper | |
| GB201515570D0 (en) | Anti-LAG-3 antibodies | |
| GB201515572D0 (en) | Anti-LAG-3 antibodies |